MSB (ASX) share price forecast & AI signal — Mesoblast Limited
Week of 2026-10-30 · Pharmaceuticals, Biotechnology & Life Sciences
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in MSB
Mesoblast Limited is a Pharmaceuticals, Biotechnology & Life Sciences stock listed on the ASX. For the week of 2026-10-30 the ACE machine-learning model rates it a SELL with moderate confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About Mesoblast Limited
Mesoblast Ltd is a biotechnology company focused on developing innovative cell-based medicines to treat inflammatory diseases.
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $2.03 |
| 2026-11-05 | $2.17 |
| 2026-11-04 | $2.10 |
| 2026-11-03 | $2.16 |
| 2026-11-02 | $2.16 |
| 2026-10-30 | $2.26 |
| 2026-10-29 | $2.32 |
MSB FAQ
Is Mesoblast Limited (MSB) a buy or sell this week?
The ACE Stock Bots machine-learning model rates MSB a SELL for the week of 2026-10-30 with moderate confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for MSB?
Every week the model scores MSB across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Pharmaceuticals, Biotechnology & Life Sciences stocks on the ASX
This week's top ASX picks · All ASX stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.